Literature DB >> 10451008

Pneumococcal disease in Sweden: experiences and current situation.

A Ortqvist1.   

Abstract

During the last decade, the incidence of invasive pneumococcal disease in Sweden has risen, seemingly due chiefly to an increasing incidence of pneumococcal bacteremia among the elderly. On the other hand, mortality due to invasive disease in Sweden is low, approximately 10% for bacteremic pneumococcal pneumonia. Beta-lactam resistance in Streptococcus pneumoniae is still a relatively minor problem in Sweden, with only 3%-4% of strains demonstrating decreased susceptibility to penicillin. However, local outbreaks of pneumococcal disease with up to 10% resistance have occurred among children, especially in southern Sweden.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451008     DOI: 10.1016/s0002-9343(99)00101-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis       Date:  2002-01

3.  It's time to step up the management of community-acquired pneumonia.

Authors:  Vincent Idemyor
Journal:  J Natl Med Assoc       Date:  2002-03       Impact factor: 1.798

4.  Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system.

Authors:  Félix O Dickinson; Antonio E Pérez
Journal:  BMC Infect Dis       Date:  2005-11-15       Impact factor: 3.090

5.  Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.

Authors:  Werner C Albrich; Dominique L Monnet; Stephan Harbarth
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

6.  Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies.

Authors:  Peter Klemets; Outi Lyytikäinen; Petri Ruutu; Jukka Ollgren; J Pekka Nuorti
Journal:  BMC Infect Dis       Date:  2008-07-22       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.